Bill 118 HR 4752, also known as the Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023, is a piece of legislation introduced in the US Congress with the aim of addressing the needs of individuals suffering from Alzheimer's disease. The bill focuses on providing high-value care and support to those affected by Alzheimer's in order to ultimately find a cure for the disease.
The key provisions of the bill include increasing funding for Alzheimer's research and treatment programs, improving access to care for individuals with Alzheimer's, and enhancing support services for caregivers. The bill also aims to promote early detection and diagnosis of Alzheimer's, as well as to raise awareness about the disease and its impact on individuals and families.
Additionally, the bill seeks to establish a national strategy for addressing Alzheimer's, which would involve collaboration between federal agencies, healthcare providers, researchers, and advocacy organizations. This strategy would prioritize research efforts, improve care coordination, and enhance support services for individuals with Alzheimer's and their caregivers.
Overall, the Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023 is a comprehensive piece of legislation that aims to address the growing impact of Alzheimer's disease in the United States. By focusing on high-value care and support, the bill seeks to improve the lives of individuals with Alzheimer's and their families, while also working towards finding a cure for this devastating disease.